Therion Biologics therionbio.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1146)

Therion Biologics Corporation is engaged in the development of therapeutic vaccines for cancer and preventive vaccines for AIDS. The company has three lead programs involving multiple clinical studies for the treatment of major cancers, including prostate, colorectal, breast cancer and melanoma. The company also has a major corporate alliance with Aventis Pasteur for the development of therapeutic vaccines for colorectal and lung cancers and melanoma.

Therion Biologics Corporation is engaged in the development of therapeutic vaccines for cancer and preventive vaccines for AIDS. The company has three lead programs involving multiple clinical studies for the treatment of major cancers, including pro...Show all

Company (Dead / Inactive)

Phone: 617-475-7500

Fax: 617-475-7501

76 Rogers Street

Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Therion Biologics $51M Jan 29, 2007
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Therion Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

OncoMed Pharmaceuticals

Redwood City, California, United States
AcquiredOncoMed Pharmaceuticals is a clinical-stage company focused on discovering and developing therapeutics targeting cancer stem cells, or CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor.Login to see details

GlobeImmune

Louisville, Colorado, United States
IPO / Went publicGlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines that predominately stimulate antibody production. To date, Tarmogen product candidates have been generally well tolerated in clinical trials for multiple disease indications an...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)